Shattuck Labs
Biotechnology, Austin Us, Austin, Texas, 78703, United States, 51-200 Employees
Phone Number: 91********
Who is SHATTUCK LABS
Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cance...
Read More
-
Headquarters: Austin Texas 78703 Us, Austin, Texas, 78703, United States
-
Date Founded: 2016
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2796
Does something look wrong? Fix it. | View contact records from SHATTUCK LABS
Shattuck Labs Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Shattuck Labs
Answer: Shattuck Labs's headquarters are located at Austin Us, Austin, Texas, 78703, United States
Answer: Shattuck Labs's phone number is 91********
Answer: Shattuck Labs's official website is https://shattucklabs.com
Answer: Shattuck Labs's revenue is $25 Million to $50 Million
Answer: Shattuck Labs's SIC: 2796
Answer: Shattuck Labs has 51-200 employees
Answer: Shattuck Labs is in Biotechnology
Answer: Shattuck Labs contact info: Phone number: 91******** Website: https://shattucklabs.com
Answer: Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattucks proprietary Agonist Redirected Checkpoint, ARC, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The companys lead wholly owned program, SL-172154 (SIRP-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLENTM, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both Austin, Texas and Durham, North Carolina.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month